Regeneron Pharmaceuticals (REGN) Revenue — Quarter Ended Sep 30, 2025
Revenue increased in the quarter. Both on a sequential and year-over-year basis, revenue was higher.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue increased in the quarter. Both on a sequential and year-over-year basis, revenue was higher.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$3.8B
Revenue reported for this quarter.
Quarter-over-quarter
+2.1%
Change from the immediately preceding quarter.
Year-over-year
+0.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$14.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $3.8B | +10.3% |
| Mar 31, 2025 | $3B | -3.7% |
| Jun 30, 2025 | $3.7B | +3.6% |
| Sep 30, 2025 | $3.8B | +0.9% |
Revenue performance
The reported revenue reflects growth compared to the immediately preceding quarter and the same quarter one year earlier.
Quarterly comparison
The sequential increase was larger than the year-over-year increase, suggesting that recent performance is stronger relative to the prior quarter than to the same period last year.
What to watch
The year-over-year growth rate is smaller than the sequential growth rate, which may warrant monitoring of the annual trend.